The hunt for an elusive universal coronavirus vaccine
PharmaVoice,
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback.
Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial
Overview of attention for article published in Lancet Infectious Diseases, March 2022
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (64th percentile)
Readers on
- mendeley
- 41 Mendeley
